Embedded Files
The latest report by IMARC Group, titled “India Pharmaceutical Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,“ offers a comprehensive analysis of the industry, which comprises insights into the India pharmaceutical market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The India pharmaceutical market size reached US$ 54.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 163.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032.
India Pharmaceutical Market Overview:
The pharmaceutical industry encompasses the development, production, and marketing of drugs licensed for use as medications. It operates on the pivotal frontier of biotechnology and applied chemistry, providing solutions that enhance healthcare outcomes. This sector is crucial due to its role in developing treatments that can save lives, alleviate pain, and prevent diseases. Companies within the industry undertake extensive research and development (R&D), which is both time-intensive and capital-heavy, often navigating stringent regulatory landscapes to ensure the safety and efficacy of the pharmaceuticals. The process from drug discovery to market launch is exhaustive, frequently spanning over a decade and involving multiple phases of clinical trials. Moreover, the industry is characterized by high levels of innovation, with significant investments in biopharmaceutical research aiming to address complex medical needs and emerging health crises, such as pandemics.
Get a Sample Copy of the Report at: https://www.imarcgroup.com/india-pharmaceutical-market/requestsample
India Pharmaceutical Market Trends:
The market in India is primarily driven by the increasing prevalence of chronic diseases among the vast population. This is exacerbated by an aging population and lifestyle shifts, which together broaden the spectrum of health issues requiring pharmaceutical intervention. The market is also buoyed by a robust generic drugs sector, which dominates the landscape due to its cost-effectiveness and extensive production capabilities. Moreover, government initiatives play a critical role in shaping the market's trajectory. Additionally, the Indian government's push towards a more favorable investment climate has attracted significant foreign direct investment in the pharmaceutical sector. This influx of capital enhances research, development, and manufacturing facilities, further solidifying India's position as a key player in the Indian market. The influence of technological advancements cannot be understated, with digitization and artificial intelligence increasingly integrated into pharmaceutical operations from drug discovery to distribution. This technological integration not only streamlines operations but also improves drug safety and patient outcomes. The rise of e-pharmacies and telemedicine, accelerated by the COVID-19 pandemic, has opened new distribution channels, and transformed consumer behavior towards online health services.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market.
Abbott India Ltd (Abbott Laboratories)
Aurobindo Pharma Limited
Biocon Limited
Cadila Pharmaceuticals Ltd.
Cipla Ltd.
Divi's Laboratories Limited
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline Pharmaceuticals Limited (GSK plc)
Lupin Limited
Mankind Pharma
Merck Life Science Private Limited (Merck KGaA)
Novartis India Limited (Novartis AG)
Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.)
Procter & Gamble Health Limited (The Procter & Gamble Company)
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd. (Torrent Group)
India Pharmaceutical Market Segmentation:
Breakup by Type:
Pharmaceutical Drugs
Cardiovascular Drugs
Dermatology Drugs
Gastrointestinal Drugs
Genito-Urinary Drugs
Hematology Drugs
Anti-Infective Drugs
Metabolic Disorder Drugs
Musculoskeletal Disorder Drugs
Central Nervous System Drugs
Oncology Drugs
Ophthalmology Drugs
Respiratory Diseases Drugs
Biologics
Monoclonal Antibodies (MAbS)
Therapeutic Proteins
Vaccines
Breakup by Nature:
Organic
Conventional
Breakup by Region:
North India
West and Central India
South India
East India
Key highlights of the Report:
Market Performance (2018-2023)
Market Outlook (2024-2032)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Page updated
Google Sites
Report abuse